Literature DB >> 1392562

Detection of the ganglioside N-glycolyl-neuraminyl-lactosyl-ceramide by biotinylated Escherichia coli K99 lectin.

A Ouadia1, Y Karamanos, R Julien.   

Abstract

K99 lectin from Escherichia coli was purified and biotinylated via its carboxyl groups using biocytin hydrazide and a water soluble carbodiimide. Biotinylation of two out of the nine carboxyl groups was sufficient to permit detection of the lectin by avidin and did not cause any loss of the haemagglutinating activity. It was demonstrated that the biotinylated K99 lectin retained other important properties of native K99 and that it will probably become a very sensitive detecting reagent. Indeed, it was able to bind to HeLa cells, as do intact bacteria carrying K99 fimbriae, and also to recognize N-glycolyl-neuraminyl-lactosyl-ceramide in an overlay binding assay.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392562     DOI: 10.1007/bf00731174

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  32 in total

Review 1.  Applications of avidin-biotin technology: literature survey.

Authors:  M Wilchek; E A Bayer
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Serology of Escherichia coli fimbriae.

Authors:  I Orskov; F Orskov
Journal:  Prog Allergy       Date:  1983

3.  Production of K99 antigen by enterotoxigenic Escherichia coli strains of antigen groups o8, o9, o20, and o101 grown at different conditions.

Authors:  F K de Graaf; F B Wientjes; P Klaasen-Boor
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

4.  Receptor-active glycolipids of epithelial cells of the small intestine of young and adult pigs in relation to susceptibility to infection with Escherichia coli K99.

Authors:  S Teneberg; P Willemsen; F K de Graaf; K A Karlsson
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

5.  Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells.

Authors:  I C Scaletsky; M L Silva; L R Trabulsi
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

6.  Pilus-mediated binding of bovine enterotoxigenic Escherichia coli to calf small intestinal mucins.

Authors:  M A Mouricout; R A Julien
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

7.  Adherence of bacteria to the intestine in sporadic cases of enteropathogenic Escherichia coli-associated diarrhea in infants and young children: a prospective study.

Authors:  P Sherman; B Drumm; M Karmali; E Cutz
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

8.  Escherichia coli K99 binds to N-glycolylsialoparagloboside and N-glycolyl-GM3 found in piglet small intestine.

Authors:  M Kyogashima; V Ginsburg; H C Krivan
Journal:  Arch Biochem Biophys       Date:  1989-04       Impact factor: 4.013

9.  A single-step isolation of K99 pili from B-44 strain of Escherichia coli.

Authors:  Y D Karkhanis; B S Bhogal
Journal:  Anal Biochem       Date:  1986-05-15       Impact factor: 3.365

10.  The role of lysine-132 and arginine-136 in the receptor-binding domain of the K99 fibrillar subunit.

Authors:  A A Jacobs; B H Simons; F K de Graaf
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

View more
  3 in total

1.  Use of porcine fibrinogen as a model glycoprotein to study the binding specificity of the three variants of K88 lectin.

Authors:  C L'Hôte; S Berger; S Bourgerie; Y Duval-Iflah; R Julien; Y Karamanos
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

2.  A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence.

Authors:  H H Chou; H Takematsu; S Diaz; J Iber; E Nickerson; K L Wright; E A Muchmore; D L Nelson; S T Warren; A Varki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

Review 3.  Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution.

Authors:  A Varki
Journal:  Am J Phys Anthropol       Date:  2001       Impact factor: 2.868

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.